← Leaderboards
Liang Wang
Mayo Clinic Rochester
$6,312,215
Attributed
$7,847,488
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $974.4K · FY2007–23$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$7,847,488 · 4
By mechanism
R01$7,515,068 · 3
R21$332,420 · 1
Top collaborators
- Manish Kohli6 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Manish Kohli$4,072,306
- Cynthia S Crowson$11,639,403
- Ramanathan Kadirvel$5,408,839
- David F Kallmes$16,430,103
- Juan R Cebral$5,400,452
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesMalignant Neoplasm Of ProstateBaseAllelesGene ExpressionTraitVariantGeneticTumorPlayComplexPhenotypeData SetDisease ProgressionGenome Wide Association StudyGenomeInnovationProstateReportingTechnologyGrowthCohortCellsHigh-Throughput Nucleotide Sequencing
Grant awards (19)
Functional characterization of prostate cancer risk loci by high throughput sequencing$366,156
R01 · FY2023 · CA · contact PI
Cell free nucleic acid-based biomarkers in advanced prostate cancer$568,617
R01 · FY2022 · CA · contact PI
Functional characterization of prostate cancer risk loci by high throughput sequencing$366,164
R01 · FY2022 · CA · contact PI
Cell free nucleic acid-based biomarkers in advanced prostate cancer$594,224
R01 · FY2021 · CA · contact PI
Functional characterization of prostate cancer risk loci by high throughput sequencing$380,150
R01 · FY2021 · CA · contact PI
Functional characterization of prostate cancer risk loci by high throughput sequencing$386,114
R01 · FY2020 · CA · contact PI
Cell free nucleic acid-based biomarkers in advanced prostate cancer$501,046
R01 · FY2019 · CA · contact PI
Cell free nucleic acid-based biomarkers in advanced prostate cancer$104,750
R01 · FY2019 · CA · contact PI
Cell free nucleic acid-based biomarkers in advanced prostate cancer$638,405
R01 · FY2018 · CA · contact PI
Cell free nucleic acid-based biomarkers in advanced prostate cancer$663,505
R01 · FY2017 · CA · contact PI
Genetic determinants of gene expression phenotypes in aggressive prostate cancer$550,809
R01 · FY2016 · CA · contact PI
Genetic determinants of gene expression phenotypes in aggressive prostate cancer$562,767
R01 · FY2015 · CA · contact PI
Genetic determinants of gene expression phenotypes in aggressive prostate cancer$14,312
R01 · FY2014 · CA · contact PI
Genetic determinants of gene expression phenotypes in aggressive prostate cancer$567,060
R01 · FY2013 · CA · contact PI
Genetic determinants of gene expression phenotypes in aggressive prostate cancer$609,950
R01 · FY2012 · CA · contact PI
Genetic determinants of gene expression phenotypes in aggressive prostate cancer$637,767
R01 · FY2011 · CA · contact PI
Genetic determinants of gene expression phenotypes in aggressive prostate cancer$3,272
R01 · FY2011 · CA · contact PI
Genetics of Germline Gene Expression Phenotype in Aggressive Prostate Cancer$181,320
R21 · FY2008 · CA · contact PI
Genetics of Germline Gene Expression Phenotype in Aggressive Prostate Cancer$151,100
R21 · FY2007 · CA · contact PI